In a recent article in DotMed’s Healthcare Business daily news, Philips CEO Frans van Houten talks about Philips impressive 7-fold jump in Q1 profits and the changes Philips has made to reposition the company.
In a span of six years, Philips has exited the consumer electronics market and has focused more on building an impressive healthcare portfolio. Frans van Houten said highlights include “our diagnosis and treatment business, with 5 percent order-intake growth” in the health technology sector.
Mr. van Houten reinforced Philips commitment to innovation by stating that the company is investing around 10% of revenue into R&D. The hybrid operating room technology for minimally-invasive image-guided operations called the Azurion platform is a significant launch that has the ability to make a major impact. “It represents a complete overhaul of the integrated operating suite, with a lot of software packages.”
OpenMarkets is proud to have Philips as a supplier partner. Detailed information about Philips Health products and solutions can be found in the OpenMarkets platform. Contact us to join the OpenMarkets community today!